ArticleInternational journal of surgery (London, England)2025

Development and validation of a machine learning-based risk model for metastatic disease in nmCRPC patients: a tumor marker prognostic study.

Xudong Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.